Skip to main content

Deucravacitinib Yields Higher Minimal Disease Activity Response Than Placebo in PsA

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Deucravacitinib Yields Higher Minimal Disease Activity Response Than Placebo in PsA

User login

Username

Password

Reset your password

Type	Lead	score